mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
25 Mar 2021
Historique:
received: 04 02 2021
accepted: 19 03 2021
pubmed: 27 3 2021
medline: 27 3 2021
entrez: 26 3 2021
Statut: aheadofprint

Résumé

Emerging SARS-CoV-2 variants have raised concerns about resistance to neutralizing antibodies elicited by previous infection or vaccination. We examined whether sera from recovered and naïve donors collected prior to, and following immunizations with existing mRNA vaccines, could neutralize the Wuhan-Hu-1 and B.1.351 variants. Pre-vaccination sera from recovered donors neutralized Wuhan-Hu-1 and sporadically neutralized B.1.351, but a single immunization boosted neutralizing titers against all variants and SARS-CoV-1 by up to 1000-fold. Neutralization was due to antibodies targeting the receptor binding domain and was not boosted by a second immunization. Immunization of naïve donors also elicited cross-neutralizing responses, but at lower titers. Our study highlights the importance of vaccinating both uninfected and previously infected persons to elicit cross-variant neutralizing antibodies.

Identifiants

pubmed: 33766944
pii: science.abg9175
doi: 10.1126/science.abg9175
pmc: PMC8139425
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI068618
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068635
Pays : United States

Commentaires et corrections

Type : UpdateOf
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Références

Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33211088
N Engl J Med. 2021 Apr 8;384(14):1372-1374
pubmed: 33691060
J Immunol Methods. 2007 May 31;323(1):39-54
pubmed: 17451739
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Elife. 2021 Jan 19;10:
pubmed: 33463525
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Cytometry A. 2019 Jul;95(7):722-725
pubmed: 30919583
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Elife. 2020 Oct 28;9:
pubmed: 33112236
Science. 2021 Feb 19;371(6531):850-854
pubmed: 33495308
Cell Rep Med. 2020 Jun 23;1(3):100040
pubmed: 32835303
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
Science. 2020 Aug 14;369(6505):818-823
pubmed: 32616673
JAMA. 2020 Aug 4;324(5):437-438
pubmed: 32628244
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
J Infect Dis. 2021 Feb 13;223(3):389-398
pubmed: 33140086
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
JAMA. 2021 Apr 13;325(14):1467-1469
pubmed: 33646292
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1600-1604
pubmed: 33119558
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nat Commun. 2020 Oct 27;11(1):5413
pubmed: 33110068
JAMA. 2020 Oct 6;324(13):1279-1281
pubmed: 32915201
Cell Host Microbe. 2021 May 12;29(5):819-833.e7
pubmed: 33789084
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
Cell Host Microbe. 2021 Apr 14;29(4):529-539.e3
pubmed: 33705729
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
N Engl J Med. 2021 Mar 8;384(15):1466-1468
pubmed: 33684280
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Nature. 2021 Apr;592(7852):122-127
pubmed: 33636719
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Nature. 2020 Aug;584(7819):115-119
pubmed: 32454513
Nature. 2021 Feb;590(7847):630-634
pubmed: 33276369
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Science. 2020 Jun 12;368(6496):1274-1278
pubmed: 32404477
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Cell Rep. 2020 Oct 20;33(3):108274
pubmed: 33027617
Immunity. 2018 Apr 17;48(4):799-811.e9
pubmed: 29669253
Cell Host Microbe. 2021 Jan 13;29(1):44-57.e9
pubmed: 33259788
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
N Engl J Med. 2021 Mar 17;384(15):1468-1470
pubmed: 33730471
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Sci Adv. 2021 Feb 17;7(8):
pubmed: 33597251
Immunity. 2020 Jul 14;53(1):98-105.e5
pubmed: 32561270
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Cell. 2020 Nov 12;183(4):1013-1023.e13
pubmed: 32970990
Viruses. 2020 May 06;12(5):
pubmed: 32384820
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Nat Commun. 2021 May 19;12(1):2938
pubmed: 34011939
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Biosaf Health. 2020 Dec;2(4):226-231
pubmed: 32864605

Auteurs

Leonidas Stamatatos (L)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. amcguire@fredhutch.org lstamata@fredhutch.org jmcelrat@fredhutch.org.
Department of Global Health, University of Washington, Seattle, WA, USA.

Julie Czartoski (J)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Yu-Hsin Wan (YH)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Leah J Homad (LJ)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Vanessa Rubin (V)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Hayley Glantz (H)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Moni Neradilek (M)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Emilie Seydoux (E)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Madeleine F Jennewein (MF)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Anna J MacCamy (AJ)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Junli Feng (J)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Gregory Mize (G)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Stephen C De Rosa (SC)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montréal, QC, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.

Maria P Lemos (MP)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Kristen W Cohen (KW)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

Zoe Moodie (Z)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.

M Juliana McElrath (MJ)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. amcguire@fredhutch.org lstamata@fredhutch.org jmcelrat@fredhutch.org.
Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Medicine, University of Washington, Seattle, WA, USA.

Andrew T McGuire (AT)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. amcguire@fredhutch.org lstamata@fredhutch.org jmcelrat@fredhutch.org.
Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Classifications MeSH